Tag: biotechnology
-
Seaweed Biomaterials Start-Up Gains $5M in Early Funds
A new company creating biomaterials for agriculture and consumer products from large seaweed blooms is adding $5 million in its first venture funding round.
-
Trial Okayed for Glaucoma Treatment Implant
A developer of treatments for eye diseases says it received clearance from FDA to begin a clinical trial of a sustained-release implant therapy for glaucoma.
-
Investor Backing Nanotech Drug Discovery Advances
A life science venture investor is funding further development of a lower-cost molecular-level drug discovery process using nanoscale synthetic DNA strands.
-
Biotechs Partner to Boost mRNA Manufacturing
Two companies working in synthetic biology are advancing a new process they say increases the scale and reduces costs of messenger RNA manufacturing.
-
Infographic – Biotech Index Down in Q1 2023
Since the beginning of 2023, NBI is down more than one percent, despite showing signs of life earlier in the year.
-
T-Cell Biotech Gains €17.5M in Grant, Equity Funds
A developer of engineered immune cells to treat cancer and immune deficiencies is raising €17.5 million ($US 19.1 million) in equity and grant funding from an EU agency.
-
Chewable Covid-19 Drug Reduces Viral Load, Symptoms
Clinical trial results show an experimental drug given as a chewable tablet reduces viral load and symptoms in people with mild to moderate Covid-19 disease.
-
$50M Challenge Seeks Quantum Life Science Applications
A new challenge competition seeks life science research applications for quantum computing that take advantage of the technology’s unique computational properties.
-
Industry, Academic Labs Detailing ALS Treatment Actions
Researchers from a developer of neurodegenerative disease therapies and university medical center are investigating the precise workings of a promising ALS treatment.
-
Moderna, Biotech Partner on Non-Viral Genetic Drug Delivery
Two biotechnology companies are collaborating on creating genetic therapies delivered with lipid nanoscale particles using non-viral mechanisms to reach target cells.